(Clin Exp Rheumatol[TA])
10,582 results
  • Association between serum transaminase elevations and clinical course in patients with familial Mediterranean fever. [Journal Article]
    Clin Exp Rheumatol. 2026 Oct 15. [Online ahead of print]Şentürk Öztaş N, Deniz R, … Gül ACE
  • CONCLUSIONS: Elevated serum transaminase levels can be detected in approximately 11.2% of FMF patients, and this finding is not associated with colchicine use or manifestations of FMF. Ultrasonographic evidence of hepatosteatosis was observed in nearly half of the patients. Follow-up analysis showed that serum transaminase elevations may persist in 43% of the patients, which suggests further studies to determine whether this abnormality is a feature of FMF or not.
  • Publisher Full Text (DOI)
  • Damage accrual predicts the development of lymphoma in primary Sjögren's disease. [Journal Article]
    Clin Exp Rheumatol. 2026 Oct 16. [Online ahead of print]Abrantes AM, Gaspar P, Isenberg DACE
  • CONCLUSIONS: Although damage was not associated with mortality, age at diagnosis and onset of symptoms were risk factors for mortality in pSjD. Cumulative and evolving damage, especially in the first years of disease, should raise concern about the possible development of lymphoma in these patients.
  • Publisher Full Text (DOI)
  • Serum advanced glycation end products and glyoxalase-1 levels in Behçet's disease: a cross-sectional study. [Journal Article]
    Clin Exp Rheumatol. 2026 Oct 07. [Online ahead of print]Kaplan T, Tüzün ZS, … Direskeneli HCE
  • CONCLUSIONS: Elevated levels of advanced glycation end products and decreased glyoxalase-1 levels were observed in BD. This pattern suggests that the inflammatory process in BD may be associated with AGE accumulation and attenuation of protective antioxidant/dicarbonyl-detoxification pathways. Elevated AGEs may contribute to the pathogenesis of atherosclerosis in individuals with BD.
  • Publisher Full Text (DOI)